$1.880
+0.146 (+7.74%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TVRD Prediction & Forecast by Similar Chart Analysis
Alphio's TVRD stock price prediction model matches the current Tvardi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.88 (+0.04%). The 1-week path is $1.92 (+1.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Tvardi Therapeutics Inc Stock?
While Tvardi Therapeutics has shown some positive developments, such as a recent upgrade to Overweight with a price target of $13, the current price of $1.82 reflects significant risks. The company reported a 93.85% decline over the past year and has a negative net income of -$6,457,000 for Q2 2026. Additionally, the RSI is at 45.12, indicating a lack of strong momentum. Given these factors, it may be prudent to hold rather than buy at this time, as the risks outweigh the potential rewards.
TVRD stock price ended at $1.88 on Wednesday, after rising +7.74%
Tvardi Therapeutics Inc (TVRD) last closed at $1.88, gaining +7.74%. These facts feed the 1-day and 1-week TVRD price prediction above.
Forecast Drivers
Tvardi Therapeutics Inc (TVRD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TVRD, ranked by similarity.
Seasonality analysis for TVRD
Historically the probability of a positive September return for TVRD is 47.73%. May offers the highest probability of a positive month at 50.79%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TVRD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $27.07 | $28.85 | $31.83 | +1434.33% |
| Oct 2026 | $26.89 | $29.72 | $32.92 | +1480.67% |
| Nov 2026 | $25.85 | $28.27 | $30.73 | +1403.86% |
| Dec 2026 | $23.24 | $23.44 | $27.27 | +1146.73% |
In 2026, Tvardi Therapeutics Inc (TVRD) is projected to range from $23.24 to $32.92.
Tvardi Therapeutics Inc 2026 monthly forecast
In Sep 2026, Tvardi Therapeutics Inc is projected to average $28.85, with a low of $27.07 and high of $31.83.
In Oct 2026, Tvardi Therapeutics Inc is projected to average $29.72, with a low of $26.89 and high of $32.92.
In Nov 2026, Tvardi Therapeutics Inc is projected to average $28.27, with a low of $25.85 and high of $30.73.
In Dec 2026, Tvardi Therapeutics Inc is projected to average $23.44, with a low of $23.24 and high of $27.27.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.